Moderate intermittent hypoxic conditioning to enhance vascular function and cardiorespiratory fitness in the elderly: A randomized controlled trial 2025
3 sessions per week over an 8-week period
Sessions began with a 5-min baseline period while breathing room air, followed by seven cycles of hypoxia, each lasting 5 min interspersed with 3-min periods of normoxic breathing (Figure 2). Using a gas-mixing device (AltitrainerÂź, SMTEC S.A., Nyon, Switzerland), the inspired fraction of oxygen (O2) was individually adjusted during each session to achieve a target arterial O2 saturation assessed by pulse oximetry (SpO2 = 80% from week 1 to week 4; 75% from week 5 to week 8) (Radical-7Âź, Massimo corporation, Irvine, CA, USA). Each session ended with a 5-min normoxic phase, allowing participants to return to their pre-session physiological state. In total, each session lasted 63 min, including 35 min of hypoxic breathing.
Brachial artery FMD, cardiopulmonary exercise testing (CPET), and ambulatory 24-h blood pressure were assessed at baseline (Pre), immediately post-intervention (Post 1), and 2 months later (Post 2). FMD showed a trend toward improvement in the IHC group, being significant when normalized for baseline artery diameter (p = 0.023; ηp2 = 0.150) between Pre and Post 2. Peak ventilation during CPET increased from Pre to Post 1 (p = 0.021), with no other significant CRF changes. Daytime systolic blood pressure decreased by 6 mmHg (p = 0.070, ηp2 = 0.105). No significant alterations in these outcomes were observed in the CTL group (p > 0.05). Moderate IHC enhanced mid-term endothelial function, suggesting potential to mitigate age-related vascular decline.
A Single Bout of Intermittent Hypoxia Increases Cerebral Blood Flow and Supports an Executive Function Benefit 2025
Healthy young adults (N = 24) completed an IH protocol entailing 12 alternating 5-min normoxic (PETO2 = 100 mmHg) and hypoxic (PETO2 = 50 mmHg) intervals that were normocapnic and isocapnic, and on a separate day completed a time-matched normoxic control protocol. Prior to (T0), and immediately (T1) and 30 min (T2) following each protocol, EF was assessed via the antisaccade task. Antisaccades require a goal-directed eye movement (i.e., saccade) mirror-symmetrical to a target and provide the resolution to detect subtle EF changes. As expected, hypoxic intervals decreased arterial and cerebral tissue O2 saturation and increased CBF as estimated via near-infrared spectroscopy and transcranial Doppler ultrasound (ps < 0.001). In turn, antisaccade reaction times (RT) did not differ between T0 and T1 (p = 0.29); however, at T2 a reliable RT reduction was observed (p = 0.004).
Better reaction time after intermittent hypoxia @John_Hemming . They used approximately 10% FiO2! On the other hand that other paper did not find cognitive benefits:
Safety and potential benefits of acute intermittent hypoxia in people with chronic traumatic brain injury 2025
Twelve volunteers with chronic TBI underwent four AIH sessions conducted on separate days, in which they were exposed to fifteen 30-60-s hypoxic episodes interspersed with 60-90 s of breathing ambient air. Inspired oxygen (O2) concentration during hypoxic episodes was gradually reduced from 21% (equal to ambient air, sham), to 17%, 13%, and 9%, over the course of four sessions.
No significant improvement in cognition or mood was noted after the AIH intervention.
Motor performance gradually improved over the course of the study, but no significant changes in response to TMS were found in corticospinal excitability.
AIH dosage as low as 9% O2 appears safe to use in chronic TBI, but its potential benefits remain to be investigated.
Intermittent hypoxia promotes fatty acid metabolism and improves myocardial energy homeostasis potentially via AMPKα1 pathway 2025: âIH intervention enhances fatty acid metabolism, improves mitochondrial tricarboxylic acid cycle efficiency, promotes ATP synthesis, preserves mitochondrial ultrastructure, reduces fibrosis, and improves cardiac function in MI rats, potentially through AMPKα1 pathway activation.â